During the past decade, Bekes Megyei Pandy Kalman Korhaz conducted 81 clinical trials. In the 10-year time frame, 81 clinical trials started and 47 clinical trials were completed, i.e. on average, 58% percent of trials that started reached the finish line to date. In the past 5 years, 28 clinical trials started and 33 clinical trials were completed. i.e. 117.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Bekes Megyei Pandy Kalman Korhaz" #1 sponsor was "Shire" with 10 trials, followed by "Hoffmann-La Roche" with 8 trials sponsored, "Janssen Research & Development, LLC" with 8 trials sponsored, "Amgen" with 7 trials sponsored and "Celgene" with 7 trials sponsored. Other sponsors include 63 different institutions and companies that sponsored additional 53 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bekes Megyei Pandy Kalman Korhaz" #1 collaborator was "Daiichi Sankyo Co., Ltd." with 2 trials as a collaborator, "APCER Life Sciences" with 1 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "BioInvent International AB" with 1 trials as a collaborator. Other collaborators include 16 different institutions and companies that were collaborators in the rest 26 trials.

According to Clinical.Site data, the most researched conditions in "Bekes Megyei Pandy Kalman Korhaz" are "Ulcerative Colitis" (14 trials), "Crohn's Disease" (9 trials), "Crohn Disease" (8 trials), "Systemic Lupus Erythematosus" (5 trials) and "Arthritis, Psoriatic" (4 trials). Many other conditions were trialed in "Bekes Megyei Pandy Kalman Korhaz" in a lesser frequency.

Most popular intervention types in "Bekes Megyei Pandy Kalman Korhaz" are "Drug" (101 trials), "Other" (13 trials), "Biological" (6 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (50 trials), "Etrolizumab" (4 trials), "Guselkumab" (4 trials), "Ontamalimab" (4 trials) and "Ozanimod" (3 trials). Other intervention names were less common.

The vast majority of trials in "Bekes Megyei Pandy Kalman Korhaz" are 104 trials for "All" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Bekes Megyei Pandy Kalman Korhaz". undefined are not yet recruiting, 17 are recruiting, 16 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 53 completed trials in Bekes Megyei Pandy Kalman Korhaz, undefined suspended trials, and 19 terminated clinical trials to date.

Out of the total trials that were conducted in Bekes Megyei Pandy Kalman Korhaz, 1 "Phase 1" clinical trials were conducted, 27 "Phase 2" clinical trials and 77 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 1 trials that are defined as “Not Applicable".

Bekes Megyei Pandy Kalman Korhaz has several departments that took part in Clinical trials: "Békés Megyei Pándy Kálmán Kórház; Onkologiai tanszek" - 7 trials, "Bekes Megyei Kosponti Korhaz, Dr. Rethy Pal Tagkorhaz, IV. Belgyogyaszat - 2. Gasztroenterologia" - 6 trials